English

Elekta’s Nomination Committee for the 2020 Annual General Meeting

Report this content

STOCKHOLM, November 14, 2019 – In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual General Meeting on August 22, 2019, the Chairman of the Board has convened the Nomination Committee for the 2020 Annual General Meeting by contacting the company’s largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice to the 2019 Annual General Meeting.

The Nomination Committee consists of:

  • Laurent Leksell, in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings
  • Per Colleen, appointed by the Fourth Swedish National Pension Fund
  • Tomas Flodén, appointed by AMF and AMF Funds
  • Filippa Gerstädt, appointed by Nordea Funds
  • Caroline Sjösten, appointed by Swedbank Robur Funds

The Nomination Committee will appoint one of its members as Chairman.

The Nomination Committee is to present proposals for resolutions by the 2020 Annual General Meeting of Shareholders in relation to the following: Chairman of the Annual General Meeting of Shareholders; Chairman of the Board of Directors and other members of the Board of Directors; fees to the Board of Directors; external auditor and fees to the auditor; and where deemed necessary, proposal to amend the procedure for the Nomination Committee.

Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to valberedningen@elekta.com or by letter to:
Elekta AB
Att: Nomination Committee
Box 7593
SE-103 93 Stockholm
Sweden

In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Committee no later than June 1, 2020.

# # #

For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Documents & Links